Clinical Trials
2 trialsNCT05139602 2026-02-13
A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy
AbbVie
Phase 2 Active not recruiting
NCT01635764 2018-01-24
PIONEER (OLE)
AbbVie
Phase 3 Completed